Your institution may have access to this item. Find your institution then sign in to continue.
Title
Uptake of oxaliplatin and bevacizumab for treatment of node-positive and metastatic colon cancer.
Authors
Neugut, Alfred I; Becker, Daniel J; Insel, Beverly J; Hershman, Dawn L
Abstract
In 2004, the US Food and Drug Administration approved bevacizumab and oxaliplatin for use in metastatic colon cancer and oxaliplatin for localized colon cancer. We investigated the diffusion and predictors of use of these medications in the year after approval.
Publication
Journal of oncology practice, 2012, Vol 8, Issue 3, p156